関連する実験動画

Updated: Apr 8, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.7K

マスクネに対するインコボトリヌム毒素Aの有効性: 予見性,単一センター,プラセボ制御,ダブルブラインド試験における評価

Alena Roessle1, Stefanie Gluecklich1, Martina Kerscher1

  • 1Cosmetic Science, Institute of Biochemistry and Molecular Biology, University of Hamburg, Germany.

Journal of cosmetic dermatology
|August 23, 2025
PubMed
まとめ

インコボトリヌムトキシンA (INCO) の皮膚内注射は,マスクネで苦しんでいる女性の皮膚の質を大幅に改善しました. この治療は皮膚の粗さ,脂質,毛穴の大きさ,赤血腫を軽減し,マスクに関連する皮膚の問題に有望な解決策を提供しました.

キーワード:
コロナウイルスインコボチウム毒素a (INCO)ボトリン毒素マスクマスクネ皮膚 質 の アクネ

さらに関連する動画

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

23.3K
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

2.8K

関連する概念動画

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
339
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
213